Pioneering Parkinson's Care: The First NHS Outcomes using the Kneu Health Platform

Kneu Health, a pioneering digital health company, is proud to share the outstanding outcomes from its first NHS service evaluation. Working with East Suffolk and North Essex NHS Foundation Trust (ESNEFT), Kneu Health has supported 90 people with Parkinson's disease over the past six months, showcasing significant improvements in patient care and clinical efficiency.

Key Outcomes:

• Enhanced Clinical Outcomes: Clinicians reported significant improvements in care and clinical outcomes for 90% of patients.
• Improved Patient Care: 53% of patients experienced changes in their care, including optimized medication and more appropriate treatment regimens.
• Increased Patient Quality of Life: Continuous app usage increased patient knowledge, empowerment, and confidence around their condition, improving quality of life by an average of 12%.
• Efficiency Savings: NHS services saw 20% efficiency savings, enabling more effective care delivery and saving time and money for the health service.
• Better Clinician Knowledge: Clinicians' understanding of their patients improved in 100% of cases, allowing for enhanced care delivery.
• Facilitation of Remote Care: The technology enabled patient-initiated follow-ups and remote consultations in approximately 50% of cases.

The Kneu Health solution includes a prescribed app that utilizes smartphone sensors to objectively measure clinical symptoms remotely, including voice, balance, walking, finger dexterity, reaction time, tremor, and cognition. Non-motor symptoms and medication adherence are also collected, and the data becomes immediately available to the patient's clinical team via an online dashboard. This provides a comprehensive and longitudinal view of a patient's condition outside the clinic environment.

"These outcomes demonstrate the real-life impact, value, and long-term potential of Kneu Health's technology in enhancing care and improving healthcare services," said Dr Kinan Muhammed, CMO and Co-Founder at Kneu Health. "Our goal is to make Parkinson's and dementia care more accessible, objective and efficient, and the results from ESNEFT are evidence for what can be achieved with innovative digital health solutions."

Kneu Health's technology not only supports patients but also enables clinicians with better insights, ultimately leading to improved care delivery and patient outcomes.

The results of the service evaluation data have also been features by Parkinson's UK Excellence Network, recognising the impact that has been made in the NHS: PUK Article Link

About Kneu Health

Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.